↓ Skip to main content

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

Overview of attention for article published in Journal of Neuro-Oncology, July 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs
1 blog
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
109 Mendeley